Literature DB >> 3802533

Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases.

A P van Zanten, A Twijnstra, A A Hart, B W Ongerboer de Visser.   

Abstract

Lactate dehydrogenase activities were determined in CSF from 350 patients suffering from various neurological diseases. Reference values were established as 0-26 U/l. Slight elevations of CSF LDH activities were observed in patients with the following disorders: brain metastasis and spinal epidural metastasis from solid carcinomas, primary central nervous system tumours, cerebrovascular accident, polyneuropathy and head injury. Marked elevations were observed incidentally in patients in these groups and in a considerable number of patients with bacterial meningitis and with leptomeningeal spread from solid or haematologic malignancies. When other diagnostic information is available for the proper estimation of the pre-test likelihood of disease, CSF LDH activities exceeding 50 U/l are suggestive for meningeal carcinomatosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3802533     DOI: 10.1016/0009-8981(86)90009-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

Review 2.  Leukemia and the nervous system.

Authors:  Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

3.  SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).

Authors:  Chanida Vinayanuwattikun; Siyamol Mingmalairak; Nutchawan Jittapiromsak; Iyavut Thaipisuttikul; Virote Sriuranpong; Apiwat Mutirangura; Shanop Shuangshoti
Journal:  J Neurooncol       Date:  2016-07-11       Impact factor: 4.130

Review 4.  Novel methods to diagnose leptomeningeal metastases in breast cancer.

Authors:  Lindsay Angus; John W M Martens; Martin J van den Bent; Peter A E Sillevis Smitt; Stefan Sleijfer; Agnes Jager
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

Review 5.  Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

Authors:  Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

6.  Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.

Authors:  A P van Zanten; A Twijnstra; B W Ongerboer de Visser; P van Heerde; A A Hart; W J Nooyen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

Review 7.  Neoplastic meningitis.

Authors:  Ana Aparicio; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

8.  Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.

Authors:  A Twijnstra; B W Ongerboer de Visser; A P van Zanten; A A Hart; W J Nooyen
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

Review 9.  Neoplastic meningitis.

Authors:  Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

10.  Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value.

Authors:  U Herrlinger; H Wiendl; M Renninger; H Förschler; J Dichgans; M Weller
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.